Sickle cell disease affects millions of people throughout the world. Acute chest syndrome is a major cause of illness and death in people with sickle cell disease. Symptoms include fever, chest pain and a raised white blood cell count. Acute infection of the lung tissue is a major cause of acute chest syndrome. Antibiotics are often given to treat these lung infections, but there is no worldwide standard treatment. We searched for randomised controlled trials which compared antibiotics (alone or in combination) with other antibiotics, placebo or standard treatment. We wanted to know if the different antibiotic treatments were effective, if they were safe, and which doses worked best for acute chest syndrome in people with sickle cell disease. This update was unable to find any trials to include in this review. We conclude that a randomised controlled trial should attempt to answer these questions. Until there is firm evidence, clinicians should treat acute chest syndrome on a case by case basis and according to the diagnosis and the treatment available.
Antibiotics for treating acute chest syndrome in people with sickle cell disease
Have your say!
'Your views on The Cochrane Library: survey'
Published Online:
January 20, 2010
More like this
- Inhaled drugs for opening up the airways in cases of acute chest syndrome in people with sickle cell disease
- Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease
- Blood transfusions for treating acute chest syndrome in people with sickle cell disease
- Review of medicines for relieving pain in sickle cell disease
- Antibiotics for treating pneumonia caught outside of hospital or care homes in people with sickle cell disease
